JP Morgan Upgrades Alnylam Pharma To Overweight
March 11, 2016 at 08:46 AM EST
JPMorgan’s Anupam Rama upgraded the rating for Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from Neutral to Overweight, while ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.